Tobias Moser

Emailt.mosersalkat

Research activity per year

18 Original Article (Journal)
11 published Abstract (Journal)
4 Case report
4 Review article
More

4 results

Filter

2024
Beyond T cell toxicity-Intrathecal chemokine C-X-C motif ligand indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review
Otto, F. (First author), Seiberl, M. (Co-author), Lara, B. (Co-author), Moser, T. (Co-author), Kleindienst, W. (Co-author), Walter, W.-E. (Co-author), Peter, K. (Co-author), Wipfler, P. (Co-author) & Harrer, A., Jul 2024, In: EUROPEAN JOURNAL OF NEUROLOGY. 31, 7, p. e16279 6 p.
Research output: Contribution to journal › Case report › peer-review

Open Access
2 Citations (Web of Science)
2023
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
TENSION Investigators, Bendszus, M., Fiehler, J., Subtil, F., Bonekamp, S., Aamodt, A. H., Fuentes, B., Gizewski, E. R., Hill, M. D., Krajina, A., Pierot, L., Simonsen, C. Z., Zeleňák, K., Blauenfeldt, R. A., Cheng, B., Denis, A., Deutschmann, H., Dorn, F., Flottmann, F. & Gellißen, S. & 31 others, Gerber, J. C., Goyal, M., Haring, J., Herweh, C., Hopf-Jensen, S., Hua, V. T., Jensen, M., Kastrup, A., Keil, C. F., Klepanec, A., Kurča, E., Mikkelsen, R., Möhlenbruch, M., Müller-Hülsbeck, S., Münnich, N., Pagano, P., Papanagiotou, P., Petzold, G. C., Pham, M., Puetz, V., Raupach, J., Reimann, G., Ringleb, P. A., Schell, M., Schlemm, E., Schönenberger, S., Tennøe, B., Ulfert, C., Vališ, K., Vítková, E. & Vollherbst, D. F., 11 Nov 2023, In: LANCET . 402, 10414, p. 1753-1763 11 p.
Research output: Contribution to journal › Case report › peer-review
2020

Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination.
Feige, J., Moser, T. (Co-author), Hauer, L. (Co-author), Pikija, S. (Co-author) & Sellner, J., 2020, In: VACCINES. 8, 1
Research output: Contribution to journal › Case report › peer-review

2 Citations (Web of Science)
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Otto, F. (First author), Moser, T. (Co-author), Feige, J. (Co-author), Seiberl, M. (Co-author), Bieler, L. & Sellner, J. (Last author), 15 Apr 2020, In: Multiple Sclerosis and Related Disorders. 42, p. 102108
Research output: Contribution to journal › Case report › peer-review

Tobias Moser

Research output

Search results

Beyond T cell toxicity-Intrathecal chemokine C-X-C motif ligand indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial

Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination.

Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.